185 related articles for article (PubMed ID: 23672482)
21. Delivery of TGF-beta1 and chondrocytes via injectable, biodegradable hydrogels for cartilage tissue engineering applications.
Park H; Temenoff JS; Holland TA; Tabata Y; Mikos AG
Biomaterials; 2005 Dec; 26(34):7095-103. PubMed ID: 16023196
[TBL] [Abstract][Full Text] [Related]
22. Assessment of growth factor treatment on fibrochondrocyte and chondrocyte co-cultures for TMJ fibrocartilage engineering.
Kalpakci KN; Kim EJ; Athanasiou KA
Acta Biomater; 2011 Apr; 7(4):1710-8. PubMed ID: 21185408
[TBL] [Abstract][Full Text] [Related]
23. Translating the application of transforming growth factor-β1, chondroitinase-ABC, and lysyl oxidase-like 2 for mechanically robust tissue-engineered human neocartilage.
Kwon H; O'Leary SA; Hu JC; Athanasiou KA
J Tissue Eng Regen Med; 2019 Feb; 13(2):283-294. PubMed ID: 30557915
[TBL] [Abstract][Full Text] [Related]
24. Driving cartilage formation in high-density human adipose-derived stem cell aggregate and sheet constructs without exogenous growth factor delivery.
Dang PN; Solorio LD; Alsberg E
Tissue Eng Part A; 2014 Dec; 20(23-24):3163-75. PubMed ID: 24873753
[TBL] [Abstract][Full Text] [Related]
25. Transient supplementation of anabolic growth factors rapidly stimulates matrix synthesis in engineered cartilage.
Ng KW; O'Conor CJ; Kugler LE; Cook JL; Ateshian GA; Hung CT
Ann Biomed Eng; 2011 Oct; 39(10):2491-500. PubMed ID: 21833681
[TBL] [Abstract][Full Text] [Related]
26. Systematic assessment of growth factor treatment on biochemical and biomechanical properties of engineered articular cartilage constructs.
Elder BD; Athanasiou KA
Osteoarthritis Cartilage; 2009 Jan; 17(1):114-23. PubMed ID: 18571441
[TBL] [Abstract][Full Text] [Related]
27. Expansion of human articular chondrocytes and formation of tissue-engineered cartilage: a step towards exploring a potential use of matrix-induced cell therapy.
Munirah S; Samsudin OC; Aminuddin BS; Ruszymah BH
Tissue Cell; 2010 Oct; 42(5):282-92. PubMed ID: 20810142
[TBL] [Abstract][Full Text] [Related]
28. Effect of double growth factor release on cartilage tissue engineering.
Ertan AB; Yılgor P; Bayyurt B; Calıkoğlu AC; Kaspar C; Kök FN; Kose GT; Hasirci V
J Tissue Eng Regen Med; 2013 Feb; 7(2):149-60. PubMed ID: 22081628
[TBL] [Abstract][Full Text] [Related]
29. Mold-shaped, nanofiber scaffold-based cartilage engineering using human mesenchymal stem cells and bioreactor.
Janjanin S; Li WJ; Morgan MT; Shanti RM; Tuan RS
J Surg Res; 2008 Sep; 149(1):47-56. PubMed ID: 18316094
[TBL] [Abstract][Full Text] [Related]
30. Tissue growth modeling in a wavy-walled bioreactor.
Bilgen B; Uygun K; Bueno EM; Sucosky P; Barabino GA
Tissue Eng Part A; 2009 Apr; 15(4):761-71. PubMed ID: 18847355
[TBL] [Abstract][Full Text] [Related]
31. Hydrodynamic parameters modulate biochemical, histological, and mechanical properties of engineered cartilage.
Bueno EM; Bilgen B; Barabino GA
Tissue Eng Part A; 2009 Apr; 15(4):773-85. PubMed ID: 18803479
[TBL] [Abstract][Full Text] [Related]
32. Modulation of intracellular reactive oxygen species level in chondrocytes by IGF-1, FGF, and TGF-beta1.
Jallali N; Ridha H; Thrasivoulou C; Butler P; Cowen T
Connect Tissue Res; 2007; 48(3):149-58. PubMed ID: 17522998
[TBL] [Abstract][Full Text] [Related]
33. TGF-β1, GDF-5, and BMP-2 stimulation induces chondrogenesis in expanded human articular chondrocytes and marrow-derived stromal cells.
Murphy MK; Huey DJ; Hu JC; Athanasiou KA
Stem Cells; 2015 Mar; 33(3):762-73. PubMed ID: 25377511
[TBL] [Abstract][Full Text] [Related]
34. Insulin in tissue engineering of cartilage: a potential model system for growth factor application.
Kellner K; Schulz MB; Göpferich A; Blunk T
J Drug Target; 2001; 9(6):439-48. PubMed ID: 11822816
[TBL] [Abstract][Full Text] [Related]
35. Biodegradable chitosan scaffolds containing microspheres as carriers for controlled transforming growth factor-beta1 delivery for cartilage tissue engineering.
Cai DZ; Zeng C; Quan DP; Bu LS; Wang K; Lu HD; Li XF
Chin Med J (Engl); 2007 Feb; 120(3):197-203. PubMed ID: 17355821
[TBL] [Abstract][Full Text] [Related]
36. Human cartilage fragments in a composite scaffold for single-stage cartilage repair: an in vitro study of the chondrocyte migration and the influence of TGF-β1 and G-CSF.
Marmotti A; Bonasia DE; Bruzzone M; Rossi R; Castoldi F; Collo G; Realmuto C; Tarella C; Peretti GM
Knee Surg Sports Traumatol Arthrosc; 2013 Aug; 21(8):1819-33. PubMed ID: 23143386
[TBL] [Abstract][Full Text] [Related]
37. Growth factor stimulation improves the structure and properties of scaffold-free engineered auricular cartilage constructs.
Rosa RG; Joazeiro PP; Bianco J; Kunz M; Weber JF; Waldman SD
PLoS One; 2014; 9(8):e105170. PubMed ID: 25126941
[TBL] [Abstract][Full Text] [Related]
38. Mesenchymal stem cells with IGF-1 and TGF- β1 in laminin gel for osteochondral defects in rabbits.
Gugjoo MB; Amarpal ; Abdelbaset-Ismail A; Aithal HP; Kinjavdekar P; Pawde AM; Kumar GS; Sharma GT
Biomed Pharmacother; 2017 Sep; 93():1165-1174. PubMed ID: 28738525
[TBL] [Abstract][Full Text] [Related]
39. Effects of in vitro preculture on in vivo development of human engineered cartilage in an ectopic model.
Moretti M; Wendt D; Dickinson SC; Sims TJ; Hollander AP; Kelly DJ; Prendergast PJ; Heberer M; Martin I
Tissue Eng; 2005; 11(9-10):1421-8. PubMed ID: 16259597
[TBL] [Abstract][Full Text] [Related]
40. IGF-I induces adipose derived mesenchymal cell chondrogenic differentiation in vitro and enhances chondrogenesis in vivo.
Zhou Q; Li B; Zhao J; Pan W; Xu J; Chen S
In Vitro Cell Dev Biol Anim; 2016 Mar; 52(3):356-364. PubMed ID: 26822434
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
